LCID stock · ORMP stock

LCID vs ORMP

Lucid Group Inc (LCID) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.

Lucid Group Inc (LCID) is a auto manufacturers company listed on NASDAQ. It is led by Peter Rawlinson.

Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.

Latest reported LCID revenue for 2025-12-31 was $1.35B. Net income was -$2.70B. Revenue was up 67.6% from 2024-12-31 to 2025-12-31. LCID currently screens at market cap $2.04B.

Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.

LCID currently screens at market cap $2.04B. ORMP currently screens at market cap $87.2M.

Not investment advice. Open the LCID and ORMP stock pages for the full models.

Not investment advice.

Popular Stock Comparisons